As of 2025-05-22, the Fair Value of BetterLife Pharma Inc (BETR.CN) is -0.16 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.11 CAD, the upside of BetterLife Pharma Inc is -243.50%.
With the market price of 0.11 CAD and our fair value calculation, BetterLife Pharma Inc (BETR.CN) is not a good investment. Investing in BETR.CN stocks now will result in a potential loss of 243.50%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-01-31 | 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | 5Y Avg | |
| Net income | -0.04 | -9.25 | -19.59 | -36.35 | -12.16 | -15.48 |
| YoY growth | 99.51% | -21,753.11% | -111.66% | -85.57% | 66.55% | -4,356.86% |
| Market Cap (mil) | 14.24 |
| P/E | |
| Forward P/E |
| EPS | -0.03 |
| Avg earnings growth rate | -4,356.86% |
| TTM earnings | -4.09 |